0001628280-26-045649
SEC filingICON plc filed its annual report on Form 6-K, including restated FY2025 financials following an accounting investigation, and provided notice of its 2026 Annual General Meeting.
The filing contains ICON plc's audited IFRS financial statements for the year ended 31 December 2025, which include a significant restatement of prior period results following an investigation into revenue recognition practices. The investigation, initiated in October 2025, identified improper adjustments to clinical trial services revenue and errors in cost estimates, resulting in a $92.7 million reduction in previously reported 2024 revenue and a $52.3 million reduction in 2024 net income. The restatement also decreased retained earnings as of 1 January 2024 by $29.3 million. The Group has self-reported the matter to the SEC.
Operating performance in 2025 was weak: revenue grew only 0.8% to $8.25 billion, while GAAP operating profit plummeted 58.8% to $427.1 million, driven by a $367.6 million goodwill impairment and $101.0 million impairment of non-financial assets in the Data Solutions reporting unit, reflecting revised expectations for that business. Excluding exceptional items, operating profit fell 12.6%. Net income dropped 70.6% to $214.0 million, with diluted EPS of $2.71 versus $8.75 in 2024.
The company also announced leadership changes: CEO Steve Cutler retired effective 1 October 2025 and was succeeded by COO Barry Balfe. Additionally, Kevin Egan and Jeff Elliott joined the Board on 1 June 2026. The AGM notice includes proposals for director elections and share issuance authorities.
On the financing side, ICON continued share repurchases, spending $750 million in 2025 and maintaining $750 million in remaining authorization. In April 2026, the company entered a $500 million bridge facility to refinance its 2026 Notes. The Data Solutions business was divested on 8 May 2026 via a merger with HealthVerity, with ICON receiving an equity stake valued at $nil.
Overall, the filing highlights a challenging year with accounting restatements, significant impairments, and management changes, but the liquidity position remains solid with $647 million cash and $500 million undrawn revolver.